Vedanta Biosciences IPO

vedantabio.com

Vedanta Biosciences is a biotechnology company focused on developing a potential new category of oral therapies based on rationally-defined consortia of bacteria derived from the human microbiome.

Founded1900
Total Funding to Date$211.6MM
Register for Details

For more details on financing and valuation for Vedanta Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Vedanta Biosciences Ticker Symbol

Vedanta Biosciences does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Vedanta Biosciences Stock Price

The stock price for Vedanta Biosciences will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Vedanta Biosciences Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
7/16/2021 Series D $68.41MM raised $XXX.XX $XXX.XX
9/23/2019 Series C-2 $41.57MM raised $XXX.XX $XXX.XX
5/13/2019 Series C $45.39MM raised $XXX.XX $XXX.XX
12/21/2018 Series B $52.23MM raised $XXX.XX $XXX.XX
11/3/2017 Series A-1 $4MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Vedanta Biosciences in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM